Dr. Ishu Kataria

Advancing public health through evidence, policy, and people-centered action.

I work at the intersection of research, implementation, and policy to design and strengthen programs that reduce the burden of cancer and noncommunicable diseases. My work focuses on translating data and real-world evidence into solutions that improve population health  particularly across low- and middle-income settings.

Work With Me

Associated with

Turning evidence into action for better health outcomes.

I support global-health organizations, governments, and research partners in developing practical, scalable strategies that address growing NCD and cancer challenges. My approach blends scientific rigor with policy insight to ensure that interventions are effective, equitable, and grounded in local context.

Core Expertise

f

Cancer Prevention & Control

Strengthening early-detection pathways, improving access to care, and supporting national cancer-control planning.

Implementation Science

Designing and evaluating real-world interventions to ensure programs deliver measurable and sustainable impact.

b

Health Economics & Policy

Applying economic modeling and policy analysis to inform high-value public-health investment decisions.

Advocacy & Capacity Development

Driving collaboration, building leadership in global health, and shaping agendas on cancer and NCDs.

Featured Projects

Access Cancer Care India

Advancing multi-cancer early detection by integrating screening models within primary care systems.

HPV Vaccine Preparedness

Supporting state-level planning and evidence generation for HPV vaccine introduction across India.

Better Health Programme – Malaysia

Guiding community-based NCD prevention initiatives for underserved, urban populations.

Women, Power & Cancer (Global)

Contributing gender-equity and policy insights to global efforts aimed at strengthening women’s roles in cancer prevention and care.

Research and leadership recognized globally

My publications appear in leading journals including Nature, The Lancet, BMJ, and Lancet Oncology. Through advisory roles, board memberships, and global commissions, I contribute to shaping the future of cancer prevention and NCD control.
9

WomenLift Health Fellow (2025–26)

9

Board Member, NCD Alliance

9
Visiting Senior Lecturer, King’s College London
9
Advisor, Cancer Research UK

Let’s create meaningful health impact together

Whether you’re designing new programs, evaluating interventions, or seeking expert advisory for cancer and NCD efforts, I’m here
to help transform evidence into sustainable solutions.